J Alzheimers Dis
-
Publication Venue For
- APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.. 79:511-530. 2021
- Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.. 80:1281-1297. 2021
- Hemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohort.. 79:1203-1211. 2021
- A Prospective Longitudinal Study of Caregivers of Community Dwelling Persons with Severe Dementia (PISCES): Study Protocol.. 75:403-416. 2020
- Co-Prevalence of Alzheimer's Disease and Age-Related Macular Degeneration Established by Histopathologic Diagnosis.. 76:207-215. 2020
- Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer's Disease.. 74:563-578. 2020
- How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?. 74:625-636. 2020
- Late-Life Cognitive Trajectories and their Associated Lifestyle Factors.. 73:1555-1563. 2020
- Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial.. 77:1793-1803. 2020
- The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.. 75:1319-1328. 2020
- A δ Homolog for Dementia Case Finding with Replication in the Alzheimer's Disease Neuroimaging Initiative.. 67:67-79. 2019
- Association Between Insulin Resistance, Plasma Leptin, and Neurocognition in Vascular Cognitive Impairment.. 71:921-929. 2019
- Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers.. 67:911-921. 2019
- Neurotransmitter Imbalance in the Brain and Alzheimer's Disease Pathology.. 72:35-43. 2019
- Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.. 64:49-54. 2018
- Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.. 66:1095-1104. 2018
- Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.. 64:1137-1148. 2018
- Effectiveness of a Personalized Brain-Computer Interface System for Cognitive Training in Healthy Elderly: A Randomized Controlled Trial.. 66:127-138. 2018
- Homocysteine and Cerebral Atrophy: The Epidemiology of Dementia in Singapore Study.. 62:877-885. 2018
- Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery-20181.. 66:1-10. 2018
- Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment.. 64:137-148. 2018
- Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment.. 55:1123-1130. 2017
- The Association Between Retinal Neuronal Layer and Brain Structure is Disrupted in Patients with Cognitive Impairment and Alzheimer's Disease.. 54:585-595. 2016
- The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.. 52:1299-1310. 2016
- Validation of the Total Cerebrovascular Disease Burden Scale in a Community Sample.. 52:1021-1028. 2016
- Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.. 49:991-1003. 2016
- Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment.. 49:1191. 2016
- Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data.. 46:695-702. 2015
- Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease.. 45:45-56. 2015
- Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment.. 48:293-301. 2015
- Subcortical Atrophy in Cognitive Impairment and Dementia.. 48:813-823. 2015
- Retinal microvasculature in Alzheimer's disease.. 42 Suppl 4:S339-S352. 2014
- Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice.. 31:359-369. 2012
- Mitochondrial DNA sequence variation associated with dementia and cognitive function in the elderly.. 32:357-372. 2012
- The importance of being connected.. 24:247-251. 2011
- Genome-wide scan of copy number variation in late-onset Alzheimer's disease.. 19:69-77. 2010
- Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA).. 18:665-675. 2009
- The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited.. 17:807-815. 2009